Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma

Augustine Lau, Steve Malangone, Myke Green, Kathryn Clarke, Ambuga Badari, Emad Elquza

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.

Original languageEnglish (US)
Pages (from-to)229-236
Number of pages8
JournalTherapeutic Advances in Medical Oncology
Volume7
Issue number4
DOIs
StatePublished - Jul 2015

Keywords

  • Bevacizumab
  • Capecitabine
  • Epithelioid
  • Hemangioendothelioma
  • Heptatic
  • Metastatic

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma'. Together they form a unique fingerprint.

  • Cite this